Valeritas Holdings is a commercial-stage medical technology company focused on improving health for people with diabetes by developing and commercializing technologies. Co.'s product, V-Go® Wearable Insulin Delivery device, is an all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. Co. developed V-Go utilizing its technology, the h-Patch platform, as a patient-focused solution to address the challenges of insulin therapies. Co.'s h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas. The VLRX average annual return 10 years is shown above.
The Average Annual Return on the VLRX average annual return 10 years page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether VLRX average annual return 10 years or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the VLRX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Video: Don't Forget Dividends in Average Annual Return!
